Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 2152 to 2201 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2152\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PP1201 PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0628846\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.276631\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22732304\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TMBIM1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2153\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STEROL REGULATORY ELEMENT BINDING PROTEIN-1 (SREBP-1) (STEROL REGULATORY ELEMENT-BINDING TRANSCRIPTION FACTOR 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0687827\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.302577\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227322962\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SREBF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2154\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Z-PROTEIN (PROTEIN CGI-119) (S1R PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0343914\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.151289\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227322542\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TMBIM4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2155\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LEUCYL-TRNA SYNTHETASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.159792\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.703125\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227259733\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LARS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2156\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROBABLE LEUCYL-TRNA SYNTHETASE, MITOCHONDRIAL PRECURSOR (EC 6.1.1.4) (LEUCINE--TRNA LIGASE) (LEURS). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.159922\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.7037\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227258775\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LARS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2157\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0141571\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0622988\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227245148\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BPIL2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2158\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MICROSOMAL SIGNAL PEPTIDASE 25 KDA SUBUNIT (EC 3.4.-.-) (SPASE 25 KDA SUBUNIT) (SPC25). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0254509\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.111998\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227244237\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SPCS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2159\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
BACTERICIDAL PERMEABILITY-INCREASING PROTEIN PRECURSOR (BPI) (CAP 57). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0196608\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0865184\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227244147\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BPI\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2160\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIPOPOLYSACCHARIDE-BINDING PROTEIN PRECURSOR (LBP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0157159\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0691587\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227244005\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LBP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2161\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
URIDINE 5'-MONOPHOSPHATE SYNTHASE (UMP SYNTHASE) [INCLUDES: OROTATE PHOSPHORIBOSYLTRANSFERASE (EC 2.4.2.10) (OPRTASE); OROTIDINE 5'- PHOSPHATE DECARBOXYLASE (EC 4.1.1.23) (OMPDECASE)]. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.485259\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.13541\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227243948\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
UMPS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2162\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CLEFT LIP AND PALATE ASSOCIATED TRANSMEMBRANE PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0206788\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0909983\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227243806\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CLPTM1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2163\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PHOSPHOLIPID TRANSFER PROTEIN PRECURSOR (LIPID TRANSFER PROTEIN II). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0139025\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0611788\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227243751\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PLTP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2164\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26S PROTEASOME NON-ATPASE REGULATORY SUBUNIT 2 (26S PROTEASOME REGULATORY SUBUNIT S2) (26S PROTEASOME SUBUNIT P97) (TUMOR NECROSIS FACTOR TYPE 1 RECEPTOR ASSOCIATED PROTEIN 2) (55.11 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.399289\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.75758\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227181124\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PSMD2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2165\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.299286\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.31793\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227087933\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2166\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
60S RIBOSOMAL PROTEIN L7. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.30758\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.35464\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227056635\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2167\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE PALMITOYLTRANSFERASE 1 (EC 2.3.1.50) (LONG CHAIN BASE BIOSYNTHESIS PROTEIN 1) (LCB 1) (SERINE-PALMITOYL-COA TRANSFERASE 1) (SPT 1) (SPT1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0595157\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.262124\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227051701\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SPTLC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2168\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLYCOGENIN-2 (EC 2.4.1.186) (GN-2) (GN2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0525739\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.231578\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227024588\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GYG2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2169\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GLYCOGENIN-1 (EC 2.4.1.186). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0648248\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.285541\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22702449\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
GYG1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2170\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PROTEIN X 0001. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0586994\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.25856\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227024288\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CRBN\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2171\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADENOSINE KINASE (EC 2.7.1.20) (AK) (ADENOSINE 5'-PHOSPHOTRANSFERASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.156968\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.691417\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.227023634\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ADK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2172\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"ORNITHINE CARBAMOYLTRANSFERASE, MITOCHONDRIAL PRECURSOR (EC 2.1.3.3) (OTCASE) (ORNITHINE TRANSCARBAMYLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.235631\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.0381\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22698295\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
OTC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2173\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEAR PORE COMPLEX PROTEIN NUP98 (NUCLEOPORIN NUP98) (98 KDA NUCLEOPORIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.245551\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.08201\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226939677\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
NUP98\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2174\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SCY1-LIKE 1; TELOMERASE REGULATION-ASSOCIATED PROTEIN; HT019 PROTEIN; TELOMERASE REGULATION-ASSOCIATED PROTEIN; N-TERMINAL KINASE-LIKE PROTEIN; TERATOMA-ASSOCIATED TYROSINE KINASE; N-TERMINAL KINASE-LIKE. \vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0350787\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.154573\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.226939375\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
SCYL1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2175\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TATA ELEMENT MODULATORY FACTOR (TMF). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
TMF1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2176\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MRNA-ASSOCIATED PROTEIN MRNP 41 (RAE1 PROTEIN HOMOLOG). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
RAE1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AMMECR1 PROTEIN. \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
AMMECR1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2178\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADENYLOSUCCINATE SYNTHASE-LIKE 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.385887\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.7008\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226885583\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ADSSL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2179\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ADENYLOSUCCINATE SYNTHETASE (EC 6.3.4.4) (IMP--ASPARTATE LIGASE) (ADSS) (AMPSASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.334139\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.47327\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226800926\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ADSS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2180\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"GLYCINE CLEAVAGE SYSTEM H PROTEIN, MITOCHONDRIAL PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.207889\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.916816\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22675106\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2181\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 6 (PAK-INTERACTING EXCHANGE FACTOR ALPHA) (ALPHA-PIX) (COOL-2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.257131\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.13453\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226640988\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARHGEF6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2182\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE-PROTEIN KINASE PAK 2 (EC 2.7.1.-) (P21-ACTIVATED KINASE 2) (PAK-2) (PAK65) (GAMMA-PAK) (S6/H4 KINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0463914\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.204773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226550375\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PAK2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2183\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE-PROTEIN KINASE PAK 3 (EC 2.7.1.-) (P21-ACTIVATED KINASE 3) (PAK-3) (BETA-PAK) (OLIGOPHRENIN-3). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.048732\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.215105\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226549825\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PAK3\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2184\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SERINE/THREONINE-PROTEIN KINASE PAK 1 (EC 2.7.1.-) (P21-ACTIVATED KINASE 1) (PAK-1) (P65-PAK) (ALPHA-PAK). \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0568471\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.250928\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.226547456\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
PAK1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2185\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CONSERVED OLIGOMERIC GOLGI COMPLEX SUBUNIT 5 (13S GOLGI TRANSPORT COMPLEX 90 KDA SUBUNIT) (GTC-90) (GOLGI TRANSPORT COMPLEX 1). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
COG5\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2186\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR 7 (PAK-INTERACTING EXCHANGE FACTOR BETA) (BETA-PIX) (COOL-1) (P85). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.214133\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.945656\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226438578\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ARHGEF7\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
U3 SNORNP PROTEIN 4 HOMOLOG. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.225682\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.996773\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226412634\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
IMP4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2188\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.19122\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.84475\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226362829\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C12orf65\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2189\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA-BINDING PROTEIN A (COLD SHOCK DOMAIN PROTEIN A) (SINGLE-STRAND DNA BINDING PROTEIN NF-GMB). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0613805\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.271164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226359325\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CSDA\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2190\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NUCLEASE SENSITIVE ELEMENT BINDING PROTEIN 1 (Y BOX BINDING PROTEIN-1) (Y-BOX TRANSCRIPTION FACTOR) (YB-1) (CCAAT-BINDING TRANSCRIPTION FACTOR I SUBUNIT A) (CBF-A) (ENHANCER FACTOR I SUBUNIT A) (EFI-A) (DNA-BINDING PROTEIN B) (DBPB). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0752905\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.332615\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226359304\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
YBX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2191\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
GERM CELL SPECIFIC Y-BOX BINDING PROTEIN; CONTRIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0582372\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.257278\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226359036\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
YBX2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2192\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEVALONATE KINASE (EC 2.7.1.36) (MK). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.562681\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.48806\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226152504\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MVK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2193\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE (EC 4.2.99.18) (AP ENDONUCLEASE 1) (APEX NUCLEASE) (APEN) (REF-1 PROTEIN). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0811054\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.358823\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226031776\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
APEX1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2194\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"DIHYDROLIPOAMIDE ACETYLTRANSFERASE COMPONENT OF PYRUVATE DEHYDROGENASE COMPLEX, MITOCHONDRIAL PRECURSOR (EC 2.3.1.12) (E2) (PDC-E2) (70 KDA MITOCHONDRIAL AUTOANTIGEN OF PRIMARY BILIARY CIRRHOSIS) (PBC) (M2 ANTIGEN COMPLEX 70 KDA SUBUNIT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.607431\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.68753\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226018314\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DLAT\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2195\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"AXONEMAL DYNEIN LIGHT INTERMEDIATE POLYPEPTIDE 1 (INNER DYNEIN ARM LIGHT CHAIN, AXONEMAL) (HP28). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.124723\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.551845\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.226010927\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DNALI1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2196\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
TUMOR SUPPRESSOR P53-BINDING PROTEIN 2 (P53-BINDING PROTEIN 2) (53BP2) (BCL2-BINDING PROTEIN) (BBP). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.097609\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.431998\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.225947805\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
TP53BP2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2197\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROTEIN PHOSPHATASE 1, REGULATORY (INHIBITOR) SUBUNIT 13B; APOPTOSIS-STIMULATING PROTEIN OF P53, 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0795635\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.352238\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.225879945\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PPP1R13B\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2198\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"60S RIBOSOMAL PROTEIN L11, MITOCHONDRIAL PRECURSOR (L11MT) (CGI-113). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.568484\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
2.51757\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.225806631\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
MRPL11\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2199\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYTOCHROME B5 REDUCTASE B5R.2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.112427\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.497956\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.225776976\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CYB5R2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2200\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYTOCHROME B5 REDUCTASE 1 (B5R.1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.11223\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.497084\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22577673\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CYB5R1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2201\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
NADH-CYTOCHROME B5 REDUCTASE (EC 1.6.2.2) (B5R). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0966308\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.427993\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.22577659\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CYB5R3\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/